- $23.62m
- $29.86m
- $0.34m
Annual income statement for Clene., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.206 | 0.723 | 0.473 | 0.654 | 0.342 |
| Cost of Revenue | |||||
| Gross Profit | 0.141 | 0.434 | 0.447 | 0.533 | 0.272 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 21 | 50.1 | 48.9 | 41.2 | 33.6 |
| Operating Profit | -20.8 | -49.3 | -48.4 | -40.5 | -33.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.9 | -10.2 | -29.9 | -49.5 | -39.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.3 | -9.74 | -29.9 | -49.5 | -39.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.3 | -9.74 | -29.9 | -49.5 | -39.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.3 | -9.74 | -29.9 | -49.5 | -39.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -21.7 | -3.3 | -9.31 | -9.43 | -5.63 |